Can simple tests performed in the primary care setting provide accurate and efficient diagnosis of benign prostatic hyperplasia? Rationale and design of the diagnosis improvement in primary care trial

International Journal of Clinical Practice

Volumn 63, Issue 8, 2009, Pages 1192-1197

  Carballido, J ^a   Fourcade, R ^b   Pagliarulo, A ^c   Cricelli, C ^d   Brenes, F ^e   Pedromingo Marino, A ^f   Castro, R ^f  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^b Centre Hospitalier d'Auxerre   (France)

^c UNIVERSITY OF BARI   (Italy)

^d Italian College of General Practitioners   (Italy)

^e Centro de Atención Primaria Llefià Badalona 6   (Spain)

^f GLAXOSMITHKLINE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIGITAL RECTAL EXAMINATION; EARLY DIAGNOSIS; EUROPE; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; MALE; MICTURITION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE HYPERTROPHY; QUALITY OF LIFE; QUESTIONNAIRE; REPRODUCIBILITY; RISK REDUCTION; SCORING SYSTEM; SYMPTOMATOLOGY;

AGED; DIAGNOSTIC TESTS, ROUTINE; FAMILY PRACTICE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATIC HYPERPLASIA; PROSTATISM; RESEARCH DESIGN; SENSITIVITY AND SPECIFICITY;

EID: 67749140061     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2009.02092.x     Document Type: Article

References (21)

1. Emberton M, Andriole GL, de la Rosette J et al. Benign prostatic hyperplasia: a progressive disease of aging men. Urology 2003 61 : 267 73.
2. McVary KT. BPH: epidemiology and comorbidities. Am J Manag Care 2006 12 : S122 8.
3. Arrighi HM, Metter EJ, Guess HA, Fozzard JL. Natural history of benign prostatic hyperplasia and risk of prostatectomy. The Baltimore Longitudinal Study of Aging. Urology 1991 38 : 4 8.
4. Verhamme KM, Dieleman JP, Bleumink GS et al. Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care - the Triumph project. Eur Urol 2002 42 : 323 8.
5. Schulman CC. The aging male: a challenge for urologists. Curr Opin Urol 2000 10 : 337 42.
6. Calais Da Silva F, Marquis P, Deschaseaux P, Gineste JL, Cauquil J, Patrick DL. Relative importance of sexuality and quality of life in patients with prostatic symptoms. Results of an international study. Eur Urol 1997 31 : 272 80.
7. Trueman P, Hood SC, Nayak US, Mrazek MF. Prevalence of lower urinary tract symptoms and self-reported diagnosed 'benign prostatic hyperplasia', and their effect on quality of life in a community-based survey of men in the UK. BJU Int 1999 83 : 410 5.
8. Van Exel NJ, Koopmanschap MA, McDonnell J et al. Medical consumption and costs during one-year follow-up of patients with LUTS suggestive of BPH in six European countries: report of the TRIUMPH study. Eur Urol 2006 49 : 92 102.
9. Madersbacher S, Alivizatos G, Nordling J, Sanz CR, Emberton M, de la Rosette JJ. EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol 2004 46 : 547 54.
10. Anderson JB, Roehrborn CG, Schalken JA, Emberton M. The progression of benign prostatic hyperplasia: examining the evidence and determining the risk. Eur Urol 2001 39 : 390 9.
11. Roehrborn CG. BPH progression: concept and key learning from MTOPS, ALTESS, COMBAT, and ALF-ONE. BJU Int 2008 101 (Suppl 3 17 21.
12. Rosenberg MT, Staskin DR, Kaplan SA, MacDiarmid SA, Newman DK, Ohl DA. A practical guide to the evaluation and treatment of male lower urinary tract symptoms in the primary care setting. Int J Clin Pract 2007 61 : 1535 46.
13. Naslund MJ, Gilsenan AW, Midkiff KD, Bown A, Wolford ET, Wang J. Prevalence of lower urinary tract symptoms and prostate enlargement in the primary care setting. Int J Clin Pract 2007 61 : 1437 45.
14. Spatafora S, Conti G, Perachino M, Casarico A, Mazzi G, Pappagallo GL. Evidence-based guidelines for the management of lower urinary tract symptoms related to uncomplicated benign prostatic hyperplasia in Italy: updated summary. Curr Med Res Opin 2007 23 : 1715 32.
15. Agence Nationale d'Accréditation et d'Évaluation en Santé (ANAES). Diagnosis and treatment of benign prostatic hyperplasia, 2003. Available at: http://www.has-sante.fr/portail/upload/docs/application/pdf/ prostatic-hyperplasia.pdf (accessed September 2008).
16. Speakman MJ, Kirby RS, Joyce A, Abrams P, Pocock R. Guideline for the primary care management of male lower urinary tract symptoms. BJU Int 2004 93 : 985 90.
17. Fourcade RO, Théret N, Taïeb C, BPH USAGE Study Group. Profile and management of patients treated for the first time for lower urinary tract symptoms/benign prostatic hyperplasia in four European countries. BJU Int 2008 101 : 1111 8.
18. McConnell JD, Roehrborn CG, Bautista OM et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med 2003 349 : 2387 98.
19. Hutchinson A, Farmer R, Chapple C et al. Characteristics of patients presenting with LUTS/BPH in six European countries. Eur Urol 2006 50 : 555 61.
20. Carballido J, Badia Llach X, Gimeno Collado A, Regadera Anechina L, Dal-ReSaavedra R, Guilera Sarda M. Validity of tests for initial diagnosis and its concordance with final diagnosis in patients with suspected benign prostatic hyperplasia. Actas Urol Esp 2006 30 : 667 74.
21. Seftel AD, Rosen RC, Rosenberg MT, Sadovsky R. Benign prostatic hyperplasia evaluation, treatment and association with sexual dysfunction: practice patterns according to physician specialty. Int J Clin Pract 2008 62 : 614 22.